🇺🇸 FDA
Pipeline program

Trastuzumab and neratinib

SYSKY-2023-075-03

Phase 3 small_molecule active

Quick answer

Trastuzumab and neratinib for Early-stage Breast Cancer is a Phase 3 program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).

Program details

Company
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Indication
Early-stage Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials